Sarosiek, Kristopher A <br/><br/>
Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Jul 2010 
 - 13069-74 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1002985107  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged, 80 and over<br/>Animals<br/>Apoptosis--drug effects<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Cell Cycle--drug effects<br/>Chlorocebus aethiops<br/>DNA Replication--drug effects<br/>Down-Regulation--drug effects<br/>E2F3 Transcription Factor--metabolism<br/>Fatal Outcome<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Herpesvirus 8, Human--drug effects<br/>Humans<br/>Lymphoma, Primary Effusion--drug therapy<br/>Male<br/>Mice<br/>NF-kappa B--metabolism<br/>Proto-Oncogene Proteins c-myc--metabolism<br/>Pyrazines--pharmacology<br/>Survival Analysis<br/>Treatment Outcome<br/>Unfolded Protein Response--drug effects<br/>Vero Cells<br/>Virion--drug effects<br/>Xenograft Model Antitumor Assays